I’ll agree if they treat Leronlimab the same way they are treating the vaccines. But if they grant it EUA as another tool in the tool box then they will need some form of sales org to,priories Leronlimab as THE treatment for s/c. Long haulers will require a sales team to help doctors differentiate between the treatments that will be out there and the complexity of long hauler symptoms because in some cases Leronlimab will fit and others it won’t